Laboratory to Bedside: Biotechnology's Place in Healthcare's Transformational Development Environment
Received: 02-Sep-2023 / Manuscript No. btbm-23-113797 / Editor assigned: 04-Sep-2023 / PreQC No. jbtbm-23-113797 (PQ) / Reviewed: 18-Sep-2023 / QC No. jbtbm-23-113797; / Manuscript No. No: jbtbm-23-113797 (R) / Accepted Date: 28-Sep-2023 / Published Date: 29-Sep-2023 DOI: 10.4172/2155-952X.1000350
Abstract
The current state of healthcare is shifting due to the fast developing field of biotechnology, which has the potential to revolutionize how illnesses are identified and treated. Healthcare biotechnology has been the topic of many great efforts, and our understanding of it has grown significantly. New biomedical paradigms are developing as a result of the most recent developments in genetics and molecular biology, igniting fresh research into brandnew solutions for human health and wellbeing. However, an exciting obstacle still exists in the practical translational development of revolutionary technological discoveries. Only a small number of biotech breakthroughs have led to brand-new, revolutionary treatments and technologies for healthcare. We shall describe the clinical translational development atmosphere for biotechnology in healthcare in this paper. Notable medical biotechnology achievements and translational promotions, including historical findings and novel perspectives are carefully covered. More groundbreaking biotech ideas are about to be translated into commercial products to bring about positive health gains, despite the fact that there are nevertheless numerous obstacles in the bench-to-bedside translational development process. This is being carried out with a tight multitude of collaboration among research institutes, healthcare providers, and industry partners.
Keywords
Bench-to-bedside; Clinical translational development; Healthcare; Biotechnology; Therapy
Introduction
In the multifaceted area of biotechnology, problems in science, technology, and healthcare can be resolved creatively using biological systems and processes. Biotechnology has its origins in the early days of civilizations. The Chinese invented methods of fermentation for brewing and creating cheese, the Aztecs utilized Spirulina algae to create cakes, and the Egyptians used yeasts to produce leavened bread [3]. Before a French chemist in 1885 postulated that some soil organisms could be able to fix airborne nitrogen into a form that plants might utilize as fertilizer, it took another 2200 years. Before a French chemist in 1885 hypothesized that some soil organisms could be able to fix the nitrogen in the air into a form that crops might utilize as fertilizer, it took another 2200 years [1, 2].
But biotechnology is only now becoming a sophisticated science, using the power of genetic engineering and molecular biology to develop new products and processes that have revolutionised the world [3]. A wide range of applications, including those in agriculture, food production, environmental management, industrial production, sickness diagnostics, and disease treatment, are currently handled by biotechnology [4]. Biotechnology has totally altered how crops are created and cultivated in agriculture. GMOs, or genetically modified organisms, are crops that have been developed to have certain
Characteristics which includes greater nutritional value, disease resistance, and greater production. Farmers have benefited from this through improving crop production and enhancing food security, particularly in developing nations where food shortage is a big issue. Biotechnology has significantly influenced the producing of biofuels, bio plastics, and other bio-based goods in the industrial sector. Biotech firms are creating renewable and sustainable substitutes for conventional fossil fuels and petroleum-based goods using microorganisms and plant-based feedstocks. This has aided in not just lowering carbon emissions while additionally boosting the biotech sector's economy and levels of employment [5].
Knowledge of genetics
Our comprehension of biology and the mechanisms of heredity is greatly influenced by the later understanding of genetics and gene function. A gene is a section of DNA that provides the instructions needed to make a particular protein. Proteins are the engine that drives cells and carry out a broad range of functions, including conveying messages between cells, catalyzing chemical processes, and providing structural support. The DNA of each gene has a particular pattern of bases, or nucleotides [6]. The "letters" that make up the genetic code can be compared to these nucleotides. The particular order of amino acids in the protein that a gene codes for is determined by the nucleotide sequence of that gene. The protein's form, purpose, and activity are consequently determined by this. The arrangement of nucleotides in a gene's DNA determines the gene's function. A gene's activity or the function of the protein it codes for might vary as a result of changes, or mutations, in the DNA sequence. While some mutations have little effect, others can result in genetic problems or help to develop illnesses like cancer [7].
Cancer therapies
The treatment of cancer is a significant area in which biotechnology has had an influence on healthcare. The capacity of the immune system to combat cancer is being harnessed by biotechnology firms in the form of immunotherapies. These treatments provide patients who previously had few alternatives fresh hope since they are frequently more efficient and less harmful than conventional chemotherapy and radiation treatments. Novel cancer therapeutics is being developed in a wide variety of forms including [8].
Drug discovery and development
Drug discovery and development In addition to the aforementioned fields, biotechnology has also had a significant impact on drug discovery and development. Biotech companies are leveraging the latest advancements in genomics, proteomics, and systems biology to identify new targets for drug development and to develop new drugs that are more effective and have fewer side effects. This has led to the development of new drugs for a range the clinical translational development of these products has therefore become a critical step in ensuring that these innovations reach the patients who need those [9]. The clinical translational development of biotechnology refers to the process of moving from laboratory research to real-world application in the healthcare industry. It involves the development of biotechnology products, such as drugs and medical devices, from initial discovery to regulatory approval and commercialization [10]. The goal of the clinical translation is to bring innovative treatments to patients that can improve health outcomes and reduce the burden of disease.
Conclusion
In conclusion, the topic of biotechnology in healthcare is one that is fast developing and has the potential to drastically alter how we identify and treat illnesses. Biotechnology, which uses the most recent developments in genetics and molecular biology, gives patients fresh hope and is reshaping the field of medicine. To make sure that the future clinical translational development of biotechnology in healthcare is maximized while its risks are minimized, government policymakers, healthcare providers, corporate companies, joint ventures, philanthropic foundations, and society as a whole must be engaged in open and informed discussions. The effective use of a multidisciplinary strategy by translational development to transform biotech ideas and discoveries into improvements in healthcare is encouraging. The innovative Benchto-Bedside technology translation concept dismantles the conventional Visionary scientists are now able to easily and creatively interact across the healthcare sectors of diagnostics, medicines, and ManTech without being constrained by academic silos or obstacles with industry. According to our writers, clinical translational progress in healthcare biotechnology will continue to improve human welfare and benefit society as a whole.
References
- Birch K, Levidow L, Papaioannou T (2010) Sustainable capital? The neoliberalization of nature and knowledge in the European “knowledge-based bio-economySustainability2:2898-2918.
- Ferreira LVS, Cammarota MC, Aguieiras GEC, Vasconcelos DSLR, Fernandez RL, et al. (2017) The protagonism of biocatalysis in green chemistry and its environmental benefits.Catalysts7: 9.
- Bell J, Paula L, Dodd T, Németh S, Nanou C, et al. (2018) EU ambition to build the world’s leading bioeconomy—Uncertain times demand innovative and sustainable solutions.N Biotechnol40: 25-30.
- Nguyen AD, Lee EY (2021) Engineered methanotrophy: a sustainable solution for methane-based industrial bio manufacturing.Trends Biotechnol39: 381-396.
- Vancov T, Alston AS, Brown T, McIntoshS (2012) Use of ionic liquids in converting lignocellulosic material to biofuels.Renewable energy45: 1-6.
- Silva SS, Gomes JM, Reis RL, Kundu SC (2021) Green solvents combined with bioactive compounds as delivery systems: present status and future trends.ACS Appl Bio Mater 4:4000-4013.
- Ncube A, MtetwaS, Bukhari M, Fiorentino G, Passaro R (2023) Circular Economy and Green Chemistry: The Need for Radical Innovative Approaches in the Design for New Products.Energies16: 1752.
- Liu J, Liang J, Xue J, Liang K (2021) Metal–organic frameworks as a versatile materials platform for unlocking new potentials in biocatalysis.Small17:2100300.
- Anastas PT, Zimmerman JB (2019) The periodic table of the elements of green and sustainable chemistry.Green Chem21: 6545-6566.
- Winkler CK, Schrittwieser JH, Kroutil W (2021) Power of biocatalysis for organic synthesis.ACS CentSci 7:55-71.
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Indexed at, Google Scholar, Crossref
Citation: Miao L (2023) Laboratory to Bedside: Biotechnology's Place in Healthcare's Transformational Development Environment. J Biotechnol Biomater, 13: 350. DOI: 10.4172/2155-952X.1000350
Copyright: © 2023 Miao L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.